Clinical Trial Update: The Metformin-FMD Trial [Phase 4]

View source ↗

Summary

Phase 4 Metformin-FMD trial has completed, investigating metformin's effects on ischemia-reperfusion injury and endothelial function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemia-reperfusion Injury

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Ischemia Reperfusion Injury, Endothelial Function | Phase 4 | Status: COMPLETED